Source link : https://www.newshealth.biz/health-news/bc-patients-see-minimal-cognitive-decline-with-cdk4-6/
Patients starting first-line endocrine and CDK4/6 inhibition for advanced breast cancer show minimal additional cognitive decline beyond what they had already experienced from their neoadjuvant and adjuvant treatments, according to new results of the SONIA trial. “Patients who are diagnosed with advanced breast cancer and start their first-line treatment already show cognitive impairments due to […]
Author : News Health
Publish date : 2024-08-01 10:34:14
Copyright for syndicated content belongs to the linked Source.
Categories